DTC Ad Letter Review Cited By GAO; Chief Counsel’s Office Adds Two To Task
Executive Summary
FDA's Office of the Chief Counsel has assigned two additional lawyers to review draft regulatory letters from the Division of Drug Marketing, Advertising & Communications
You may also be interested in...
FDA Chief Counsel Warning Letter Review To Continue After Troy’s Departure
The FDA Office of Chief Counsel's review of warning and untitled letters has resulted in the rejection of approximately 5% of letters, outgoing Chief Counsel Daniel Troy said
Warning Letter “Templates” Likely Part Of GMP Proposal In August
The Center for Drug Evaluation & Research is likely to propose warning letter "templates" as part of its revisions to the Good Manufacturing Practices regulations coming out in August
Warning Letter “Templates” Likely Part Of GMP Proposal In August
The Center for Drug Evaluation & Research is likely to propose warning letter "templates" as part of its revisions to the Good Manufacturing Practices regulations coming out in August